Share
Single Cell Analysis Market Size, Share, and Analysis, By Product (Consumable and Instruments), By Application (Cancer, Immunology, Neurology, Stem cell, Non-invasive prenatal diagnosis, and Others), By Cell Type (Human, Animal, and Microbial), and End Users (Academic & Research laboratories, Biotechnology & Pharmaceutical companies, Hospitals and Diagnostic laboratories, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032
Single Cell Analysis Market is expected to grow at a CAGR of 15.9% in the forecast period (2023-2032), with the market size valued at USD 3.20 billion in 2021 and projected to reach USD 16.2 billion by 2032, up from USD 3.7 billion in 2022.
Single-cell analysis is the study of cell interactions, genomes, transcriptomics, proteomics, and metabolomics at the single-cell level. Technology advances, expanding applications in cancer research, and higher government funding for cell-based research are the main drivers of growth in the single-cell analysis market. In addition, the market is advancing as a result of the epidemic. Single-cell RNA sequencing is used in cancer research to examine complex tissues at the level of the individual cells, identifying differences in gene expression and tracking the growth of tumors to stop further cellular degeneration.
Single Cell Analysis Market is expected to reach USD 16.2 billion, growing at a CAGR of 15.9% owing to the advances in genomics, transcriptomics, and proteomics, which enable researchers to examine biological complexity at the single-cell level. Applications in cancer research, immunology, and neuroscience are key drivers, fuelling demand for technologies such as single-cell RNA sequencing and flow cytometry. Furthermore, the industry benefits from the advancement of customized medicine and drug discovery initiatives.
Source: Fatpos Global
Based on Application, the market is divided into oncology, immunology, neurology, stem cell research, non-invasive prenatal diagnosis, in-vitro fertilization, and various others. Oncology segment registered a major share in 2021 due to its increased demand. It is anticipated that this trend will continue in the upcoming years, especially due to the continuing increase in cancer prevalence worldwide. Additionally, the success of single cell analysis in early cancer cell diagnoses has made a substantial contribution to the expansion of the oncology market. The importance of single cell analysis in advancing precision medicine and enhancing results in cancer research and diagnostics is highlighted by this.
By product, the Single Cell Analysis Market is typically segmented into consumables and instruments. Both in terms of market share and compound annual growth rate (CAGR), the consumables segment dominates this market landscape. Due to several factors, this dominance is anticipated to continue during the projection period. The consumables category benefits from high usability, frequent reagent purchases, and a steady demand resulting from the ongoing requirement for assay-related items. Additionally, as target diseases become more prevalent, this increases the demand for consumables in the field of single cell analysis, highlighting its crucial role in advancing cellular research and diagnostics.
Source: Fatpos Global
Increasing cancer prevalence to drive market growth
Single-cell analysis is critical for discovering biomarkers linked to malignancy. GLOBOCAN predicts that the number of cancer cases would reach 30 million by 2040. Cancer is a very heterogeneous disease with numerous cell types within a tumor. Researchers can use single-cell analysis to deconstruct this heterogeneity and analyze individual cancer cells at the molecular level. Researchers get a full understanding of tumor heterogeneity by examining gene expression, genetic alterations, and other biological features at the single-cell level.
Swift economic expansion to boost market growth
Rapid urbanization, digitization, improved healthcare infrastructure, and rising awareness are all anticipated to support market expansion. Additionally, the expanding interest in customized medicine and the advancement of stem cell research are anticipated to drive market expansion. Furthermore, the market's expansion during the anticipated period is tempered by the growing popularity of single-cell analysis tools.
High cost of single-cell analysis products
Single-cell analysis tools' high price points are a major barrier for poor nations' research institutes and rising markets. Investment in pricey single-cell analysis technology is made more difficult by the fact that these locations frequently have financial constraints, currency fluctuations, and restricted access to resources. Collaborations between research institutes may be hampered by the financial implications of single-cell analysis products. When the necessary equipment and reagents are expensive and not widely available, sharing data and reproducing studies becomes difficult.
Single Cell Analysis Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. According to projections, North America will hold the largest market share. The substantial market share held by North America is credited to several causes, including growing partnerships between well-known businesses, technical breakthroughs, and the expansion of the biotechnology and pharmaceutical industries.
Due to factors like expanding opportunities in cancer cell research and rising consumer awareness of medical technology advancements that have increased demand for customized treatment, Europe is predicted to experience moderate market growth. The region of Asia-Pacific is anticipated to expand at the greatest CAGR, mostly as a result of an aging population, growing government initiatives to support life science research, and expanding biotech R&D expenditures. Lower market revenue shares and growth rates are predicted to come from Latin America, the Middle East, and Africa.
Source: Fatpos Global
The COVID-19 outbreak had resulted in the economic downfall. Several countries had imposed lockdowns and applied travel restrictions to control the spread of the virus. Governments around the world increased financing for vaccine development and study as a result of the COVID-19 pandemic, which had a favorable impact on the single cell analysis sector. The demand for single-cell analysis instruments for COVID-19 investigations increased despite difficulties in production and sales brought on by governmental constraints. For proper diagnosis, prognosis, and the development of therapies for severe cases, it is essential to comprehend host immune responses at the single-cell level. Understanding the roles of immune cells through single-cell analysis helps scientists create more potent vaccines and immunotherapies.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2032 |
|
Base Year |
2022 |
|
Forecast Period |
2022-2032 |
|
Historical Period |
2019-2021 |
|
Growth Rate |
CAGR of 15.9% from 2022-2032 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
By Product |
|
|
By Application |
|
|
By Cell Type |
|
|
By End Users |
|
|
By Region |
|
Single Cell Analysis Market size was values at USD 3.20 billion in 2021 and is projected to reach the value of USD 16.2 billion in 2032, exhibiting a CAGR of 15.9% during the forecast period.
The market for tools and methods used to investigate individual cells at a high resolution is known as the "Single Cell Analysis Market." It is essential for understanding cellular activities and heterogeneity in several disciplines, including genomics, proteomics, and disease research.
The consumable segment and the oncology segment accounted for the largest single cell analysis market share.
Key players in the single cell analysis market include Illumina Inc., 10x Genomics Inc., Fluidigm Corporation, BD Biosciences, Mission Bio, NanoString Technologies, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Agilent Technologies, Miltenyi Biotec, Dolomite Bio, Bio-Techne Corporation, Zeiss Group, Abcam plc, and other prominent players.
Increasing cancer prevalence and swift economic expansion are the factors driving the Single Cell Analysis Market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
